60218-41-9CCC=C(CCC)C(=O)OZKNJEOBYOLUGKJ-UHFFFAOYSA-Nvalproate metabolite; RN given refers to parent cpd
60218-41-9DTXSID201312507Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (97.6%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory.
Drugs used to prevent SEIZURES or reduce their severity.
An agent that causes the production of physical defects in the developing embryo.
Beschreibung(E,Z)-2-propyl-2-Pentenoic acid is a bioactive metabolite of valproic acid that exhibits the same profile and potency of anticonvulsant activity in animal models as its parent compound without any observed teratogenicity and hepatotoxicity.
VerwendenA metabolite of Valproic Acid
Wird geladen…